BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fredolini C, Byström S, Pin E, Edfors F, Tamburro D, Iglesias MJ, Häggmark A, Hong MG, Uhlen M, Nilsson P, Schwenk JM. Immunocapture strategies in translational proteomics. Expert Rev Proteomics 2016;13:83-98. [PMID: 26558424 DOI: 10.1586/14789450.2016.1111141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen JM, Liu X, Deloffi M, Murisier A, Fekete S, Guillarme D, Lauber MA. Aptamer-based immunoaffinity LC-MS using an ultra-short column for rapid attomole level quantitation of intact mAbs. Journal of Chromatography B 2021;1173:122694. [DOI: 10.1016/j.jchromb.2021.122694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ibrahim S, Lan C, Chabot C, Mitsa G, Buchanan M, Aguilar-Mahecha A, Elchebly M, Poetz O, Spatz A, Basik M, Batist G, Zahedi RP, Borchers CH. Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy. Anal Chem 2021;93:10816-24. [PMID: 34324311 DOI: 10.1021/acs.analchem.1c00975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Schuster-Little N, Fritz-Klaus R, Etzel M, Patankar N, Javeri S, Patankar MS, Whelan RJ. Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites. Analyst 2021;146:85-94. [PMID: 33141132 DOI: 10.1039/d0an01701a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kosaka PM, Calleja M, Tamayo J. Optomechanical devices for deep plasma cancer proteomics. Semin Cancer Biol 2018;52:26-38. [PMID: 28867489 DOI: 10.1016/j.semcancer.2017.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
5 Byström S, Fredolini C, Edqvist PH, Nyaiesh EN, Drobin K, Uhlén M, Bergqvist M, Pontén F, Schwenk JM. Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence. Transl Oncol 2017;10:385-95. [PMID: 28433799 DOI: 10.1016/j.tranon.2017.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
6 Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA. Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia. Anal Chem 2018;90:2216-23. [PMID: 29272104 DOI: 10.1021/acs.analchem.7b04590] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
7 Teunissen CE, Otto M, Engelborghs S, Herukka SK, Lehmann S, Lewczuk P, Lleó A, Perret-Liaudet A, Tumani H, Turner MR, Verbeek MM, Wiltfang J, Zetterberg H, Parnetti L, Blennow K. White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation. Alzheimers Res Ther 2018;10:30. [PMID: 29544527 DOI: 10.1186/s13195-018-0359-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
8 Li H, Popp R, Frohlich B, Chen MX, Borchers CH. Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI). J Vis Exp 2017. [PMID: 28872133 DOI: 10.3791/55933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Pampalakis G, Zingkou E, Vekrellis K, Sotiropoulou G. “Activography”: a novel, versatile and easily adaptable method for monitoring enzymatic activities in situ. Chem Commun 2017;53:3246-8. [DOI: 10.1039/c7cc01081h] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Li H, Popp R, Chen M, Macnamara EM, Juncker D, Borchers CH. Bead-Extractor Assisted Ready-to-Use Reagent System (BEARS) for Immunoprecipitation Coupled to MALDI-MS. Anal Chem 2017;89:3834-9. [DOI: 10.1021/acs.analchem.6b04169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Huang S, Tang R, Zhang T, Zhao J, Jiang Z, Wang Q. Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients' plasma. Biosens Bioelectron 2021;171:112678. [PMID: 33113382 DOI: 10.1016/j.bios.2020.112678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Stockfelt M, Hong MG, Hesselmar B, Adlerberth I, Wold AE, Schwenk JM, Lundell AC, Rudin A. Circulating proteins associated with allergy development in infants-an exploratory analysis. Clin Proteomics 2021;18:11. [PMID: 33722194 DOI: 10.1186/s12014-021-09318-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Davis MM, Brodin P. Rebooting Human Immunology. Annu Rev Immunol 2018;36:843-64. [PMID: 29490162 DOI: 10.1146/annurev-immunol-042617-053206] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
14 Rydze RT, Patton B, Briley SM, Salazar-Torralba H, Gipson G, James R, Rajkovic A, Thompson T, Pangas SA. Deletion of Gremlin-2 alters estrous cyclicity and disrupts female fertility in mice. Biol Reprod 2021:ioab148. [PMID: 34333627 DOI: 10.1093/biolre/ioab148] [Reference Citation Analysis]
15 Lorentzian A, Uzozie A, Lange PF. Origins and clinical relevance of proteoforms in pediatric malignancies. Expert Rev Proteomics 2019;16:185-200. [PMID: 30700156 DOI: 10.1080/14789450.2019.1575206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Moritz CP, Paul S, Stoevesandt O, Tholance Y, Camdessanché J, Antoine J. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Autoimmunity Reviews 2020;19:102450. [DOI: 10.1016/j.autrev.2019.102450] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
17 Furlani IL, da Cruz Nunes E, Canuto GAB, Macedo AN, Oliveira RV. Liquid Chromatography-Mass Spectrometry for Clinical Metabolomics: An Overview. Adv Exp Med Biol 2021;1336:179-213. [PMID: 34628633 DOI: 10.1007/978-3-030-77252-9_10] [Reference Citation Analysis]
18 Alnabulsi A, Murray GI. Integrative analysis of the colorectal cancer proteome: potential clinical impact. Expert Rev Proteomics 2016;13:917-27. [PMID: 27598033 DOI: 10.1080/14789450.2016.1233062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
19 Halvorsen TG, McKitterick N, Kish M, Reubsaet L. Affinity capture in bottom-up protein analysis - Overview of current status of proteolytic peptide capture using antibodies and molecularly imprinted polymers. Anal Chim Acta 2021;1182:338714. [PMID: 34602193 DOI: 10.1016/j.aca.2021.338714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bruzelius M, Iglesias MJ, Hong M, Sanchez-rivera L, Gyorgy B, Souto JC, Frånberg M, Fredolini C, Strawbridge RJ, Holmström M, Hamsten A, Uhlén M, Silveira A, Soria JM, Smadja DM, Butler LM, Schwenk JM, Morange P, Trégouët D, Odeberg J. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood 2016;128:e59-66. [DOI: 10.1182/blood-2016-05-711846] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
21 Oh S, Kim HS. Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies. Expert Rev Proteomics 2016;13:929-39. [PMID: 27599289 DOI: 10.1080/14789450.2016.1233063] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Fredolini C, Byström S, Sanchez-Rivera L, Ioannou M, Tamburro D, Pontén F, Branca RM, Nilsson P, Lehtiö J, Schwenk JM. Systematic assessment of antibody selectivity in plasma based on a resource of enrichment profiles. Sci Rep 2019;9:8324. [PMID: 31171813 DOI: 10.1038/s41598-019-43552-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
23 Schwenk JM, Omenn GS, Sun Z, Campbell DS, Baker MS, Overall CM, Aebersold R, Moritz RL, Deutsch EW. The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays. J Proteome Res 2017;16:4299-310. [PMID: 28938075 DOI: 10.1021/acs.jproteome.7b00467] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 20.8] [Reference Citation Analysis]